Cargando…
Systemic Sclerosis and Systemic Lupus Erythematosus Overlap Syndrome with Pulmonary Arterial Hypertension Successfully Treated with Immunosuppressive Therapy and Riociguat
We report the case of a 40-year-old patient with systemic sclerosis (SSc) and systemic lupus erythematosus (SLE) overlap syndrome with pulmonary arterial hypertension (overlap-PAH) that was successfully treated with a combination of immunosuppressive therapy and the soluble guanylate cyclase stimula...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6538401/ https://www.ncbi.nlm.nih.gov/pubmed/31183306 http://dx.doi.org/10.7759/cureus.4327 |
_version_ | 1783422175671222272 |
---|---|
author | Kuzuya, Kentaro Tsuji, Soichiro Matsushita, Masato Ohshima, Shiro Saeki, Yukihiko |
author_facet | Kuzuya, Kentaro Tsuji, Soichiro Matsushita, Masato Ohshima, Shiro Saeki, Yukihiko |
author_sort | Kuzuya, Kentaro |
collection | PubMed |
description | We report the case of a 40-year-old patient with systemic sclerosis (SSc) and systemic lupus erythematosus (SLE) overlap syndrome with pulmonary arterial hypertension (overlap-PAH) that was successfully treated with a combination of immunosuppressive therapy and the soluble guanylate cyclase stimulator riociguat. She was diagnosed with mixed connective tissue disease (MCTD) two years prior to admission. She was admitted to our hospital with dyspnea on exertion and progressive skin sclerosis. She fulfilled both SLE and SSc classification criteria and was re-diagnosed with overlap syndrome. The tricuspid valve pressure gradient (TRPG) on echocardiography was 64 mmHg at admission. On right heart catheterization, mean pulmonary arterial pressure (mPAP) was 43 mmHg and pulmonary capillary wedge pressure was 15 mmHg. We diagnosed her with SSc-SLE overlap-PAH and started treatment with corticosteroids and intravenous cyclophosphamide. We also started treatment with riociguat because we speculated she had a component of SSc-PAH and that immunosuppressive therapy alone may be insufficient. We chose riociguat because of its favorable treatment effect on SSc-PAH. Two months after treatment, her TRPG improved to 33 mmHg and the skin sclerosis improved dramatically, suggesting the efficacy of multi-drug treatment and the importance of early intervention. |
format | Online Article Text |
id | pubmed-6538401 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Cureus |
record_format | MEDLINE/PubMed |
spelling | pubmed-65384012019-06-10 Systemic Sclerosis and Systemic Lupus Erythematosus Overlap Syndrome with Pulmonary Arterial Hypertension Successfully Treated with Immunosuppressive Therapy and Riociguat Kuzuya, Kentaro Tsuji, Soichiro Matsushita, Masato Ohshima, Shiro Saeki, Yukihiko Cureus Cardiology We report the case of a 40-year-old patient with systemic sclerosis (SSc) and systemic lupus erythematosus (SLE) overlap syndrome with pulmonary arterial hypertension (overlap-PAH) that was successfully treated with a combination of immunosuppressive therapy and the soluble guanylate cyclase stimulator riociguat. She was diagnosed with mixed connective tissue disease (MCTD) two years prior to admission. She was admitted to our hospital with dyspnea on exertion and progressive skin sclerosis. She fulfilled both SLE and SSc classification criteria and was re-diagnosed with overlap syndrome. The tricuspid valve pressure gradient (TRPG) on echocardiography was 64 mmHg at admission. On right heart catheterization, mean pulmonary arterial pressure (mPAP) was 43 mmHg and pulmonary capillary wedge pressure was 15 mmHg. We diagnosed her with SSc-SLE overlap-PAH and started treatment with corticosteroids and intravenous cyclophosphamide. We also started treatment with riociguat because we speculated she had a component of SSc-PAH and that immunosuppressive therapy alone may be insufficient. We chose riociguat because of its favorable treatment effect on SSc-PAH. Two months after treatment, her TRPG improved to 33 mmHg and the skin sclerosis improved dramatically, suggesting the efficacy of multi-drug treatment and the importance of early intervention. Cureus 2019-03-26 /pmc/articles/PMC6538401/ /pubmed/31183306 http://dx.doi.org/10.7759/cureus.4327 Text en Copyright © 2019, Kuzuya et al. http://creativecommons.org/licenses/by/3.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Cardiology Kuzuya, Kentaro Tsuji, Soichiro Matsushita, Masato Ohshima, Shiro Saeki, Yukihiko Systemic Sclerosis and Systemic Lupus Erythematosus Overlap Syndrome with Pulmonary Arterial Hypertension Successfully Treated with Immunosuppressive Therapy and Riociguat |
title | Systemic Sclerosis and Systemic Lupus Erythematosus Overlap Syndrome with Pulmonary Arterial Hypertension Successfully Treated with Immunosuppressive Therapy and Riociguat |
title_full | Systemic Sclerosis and Systemic Lupus Erythematosus Overlap Syndrome with Pulmonary Arterial Hypertension Successfully Treated with Immunosuppressive Therapy and Riociguat |
title_fullStr | Systemic Sclerosis and Systemic Lupus Erythematosus Overlap Syndrome with Pulmonary Arterial Hypertension Successfully Treated with Immunosuppressive Therapy and Riociguat |
title_full_unstemmed | Systemic Sclerosis and Systemic Lupus Erythematosus Overlap Syndrome with Pulmonary Arterial Hypertension Successfully Treated with Immunosuppressive Therapy and Riociguat |
title_short | Systemic Sclerosis and Systemic Lupus Erythematosus Overlap Syndrome with Pulmonary Arterial Hypertension Successfully Treated with Immunosuppressive Therapy and Riociguat |
title_sort | systemic sclerosis and systemic lupus erythematosus overlap syndrome with pulmonary arterial hypertension successfully treated with immunosuppressive therapy and riociguat |
topic | Cardiology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6538401/ https://www.ncbi.nlm.nih.gov/pubmed/31183306 http://dx.doi.org/10.7759/cureus.4327 |
work_keys_str_mv | AT kuzuyakentaro systemicsclerosisandsystemiclupuserythematosusoverlapsyndromewithpulmonaryarterialhypertensionsuccessfullytreatedwithimmunosuppressivetherapyandriociguat AT tsujisoichiro systemicsclerosisandsystemiclupuserythematosusoverlapsyndromewithpulmonaryarterialhypertensionsuccessfullytreatedwithimmunosuppressivetherapyandriociguat AT matsushitamasato systemicsclerosisandsystemiclupuserythematosusoverlapsyndromewithpulmonaryarterialhypertensionsuccessfullytreatedwithimmunosuppressivetherapyandriociguat AT ohshimashiro systemicsclerosisandsystemiclupuserythematosusoverlapsyndromewithpulmonaryarterialhypertensionsuccessfullytreatedwithimmunosuppressivetherapyandriociguat AT saekiyukihiko systemicsclerosisandsystemiclupuserythematosusoverlapsyndromewithpulmonaryarterialhypertensionsuccessfullytreatedwithimmunosuppressivetherapyandriociguat |